About MaSTherCell
MaSTherCell is a company based in Charleroi (Belgium) founded in 2011 was acquired by Catalent in February 2020. MaSTherCell has raised $17.37 million across 2 funding rounds from investors including Catalent, Hearst and Orgenesis. The company has 329 employees as of June 30, 2022. MaSTherCell offers products and services including Cosmetic Treatments and Consultations. MaSTherCell operates in a competitive market with competitors including Orgenesis, Ori Biotech, Cognate Bioservices, SpliSense and eXmoor, among others.
- Headquarter Charleroi, Belgium
- Employees 329 as on 30 Jun, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Catalent Gosselies
-
Annual Revenue
$65.41 M (USD)44as on Jun 30, 2022
-
Net Profit
-$10.38 M (USD)-38as on Jun 30, 2022
-
EBITDA
-$10.28 M (USD)-37as on Jun 30, 2022
-
Total Equity Funding
$17.37 M (USD)
in 2 rounds
-
Latest Funding Round
$11.8 M (USD), Series A
Jun 29, 2018
-
Investors
Catalent
& 6 more
-
Employee Count
329
as on Jun 30, 2022
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MaSTherCell
MaSTherCell offers a comprehensive portfolio of products and services, including Cosmetic Treatments and Consultations.
Delivers non-surgical cosmetic services using evidence-based protocols for client satisfaction.
Provides personalized advice and treatment planning for cosmetic medical needs.
Funding Insights of MaSTherCell
MaSTherCell has successfully raised a total of $17.37M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $11.8 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MaSTherCell
MaSTherCell has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Catalent, Hearst and Orgenesis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on company buyouts
|
Locked | Locked | Locked | |
|
Early to late-stage tech investments are made globally by REV.
|
Locked | Locked | Locked | |
|
VC & PE fund
|
Locked | Locked | Locked |
Investor details for MaSTherCell
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MaSTherCell
Investment portfolio details for MaSTherCell
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MaSTherCell
Detailed financials for MaSTherCell
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Masthercell Comparisons
Peer comparison for MaSTherCell
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MaSTherCell
MaSTherCell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orgenesis, Ori Biotech, Cognate Bioservices, SpliSense and eXmoor, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cell and gene therapies for multiple disorders are developed.
|
|
| Locked | Locked | Locked |
Software development services are provided for the biopharma sector.
|
|
| Locked | Locked | Locked |
Development and manufacturing services for cell-based therapies are provided.
|
|
| Locked | Locked | Locked |
Limited information available
|
|
| Locked | Locked | Locked |
Cell and gene therapeutic services are provided to biopharmaceutical firms.
|
Detailed competitors of MaSTherCell
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Masthercell
Complete news archive for MaSTherCell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MaSTherCell
MaSTherCell was founded in 2011.
MaSTherCell is headquartered in Charleroi, Belgium. It is registered at Charleroi, Walloon Region, Belgium.
MaSTherCell is a funded company, having raised a total of $17.37M across 2 funding rounds to date.
As of Jun 30, 2022, the latest employee count at MaSTherCell is 329.
Annual revenue of MaSTherCell is $65.41M as on Jun 30, 2022.
MaSTherCell (Manufacturing Synergies for Therapeutic Cells) is a Belgian Contract Development and Manufacturing Organisation, offering its services for the development of cell therapy products. Companys services include process and assay development, GMP manufacturing and quality control services of cell therapy products. The companys services can be availed right from Phase - I to commercialization of the product. Their facilities are authorized by Belgian Drug Agency (AFMPS). The company claims that their quality control services are performed in accordance with European and US pharmacopeia, FDA and EMA. MaSTherCell was acquired by Orgenesis (a company offering cellular therapy and regenerative medicines for the treatment of Type 1 Diabetes) in March 2015. In August 2016, the company was selected by Adaptimmune as a supplier of cell therapy products for use in Adaptimmunes clinical trials.
MaSTherCell's top competitors include Ori Biotech, OBiO Technology and Genflow Biosciences.
MaSTherCell offers Cosmetic Treatments and Consultations.
MaSTherCell has 7 investors. Key investors include Catalent, Hearst, Orgenesis, Biowin, and Great Point Partners.